Clarissa Desjardins is the founder of Congruence Therapeutics. Congruence Therapeutics has raised $140M in total funding. Latest round: Series B.
Clarissa Desjardins is a Montreal-based biotechnology entrepreneur and the Co-founder & CEO of Congruence Therapeutics. Her company uses machine learning and computer simulations to develop treatments for rare diseases and protein misfolding disorders. She is recognized as one of Canada's most accomplished biotechnology entrepreneurs.
Full founder directory · Investor directory · Company funding database · Fundraising library